TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PYXS

Pyxis Oncology Inc

Healthcare · Biotechnology

3.40$ +2.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Pyxis Oncology Inc (PYXS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 59.4% of the shares are freely tradable; institutional investors hold 33.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 33.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 22.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 59.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 83Mio.

Largest Shareholders

Institutions

Institutions PYXS
Name Stake (%) Shares Change (%) Date
GordonMD Global Investments LP 12.02 10,024,909 +143.2 06/30/2026
Pfizer Inc 8.43 7,032,770 +0.0 03/31/2026
LAURION CAPITAL MANAGEMENT LP 5.99 4,997,333 +4.2 03/31/2026
Vanguard Capital Management, LLC 2.44 2,033,510 +0.0 03/31/2026
Atle Fund Management AB 1.16 966,459 +390.5 06/30/2026
683 Capital Management LLC 1.07 896,263 +0.5 03/31/2026
Renaissance Technologies Corp 1.07 888,680 +22.0 03/31/2026
Palo Alto Investors, LLC 1.04 864,277 -14.5 06/30/2026
BlackRock Inc 0.95 788,839 +0.6 03/31/2026

Funds

Funds PYXS
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.93 1,612,036 +13.3 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?